TITLE:
A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.

CONDITION:
Non-Hodgkin's Lymphoma

INTERVENTION:
LY317615

SUMMARY:

      This study will measure the effectiveness and any side effects of LY317615 in patients with
      Diffuse large B-cell lymphoma (a sub-type of Non-Hodgkins Lymphoma).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  A diagnosis of recurrent or refractory Diffuse B-cell Non-Hodgkin's lymphoma.

          -  Adequate organ functions.

          -  Able to swallow capsules.

        Exclusion Criteria:

          -  More than 3 prior treatments for this disease.

          -  Serious heart problems.
      
